Fatty acid synthase as a potential new therapeutic target for cervical cancer.

Fatty acid synthase (FASN) is the rate-limiting enzyme for the de novo synthesis of fatty acids in the cytoplasm of tumour cells. Many tumour cells express high levels of FASN, and its expression is associated with a poorer prognosis. Cervical cancer is a major public health problem, representing the fourth most common cancer affecting women worldwide. To date, only a few in silico studies have correlated FASN expression with cervical cancer. This study aimed to investigate in vitro FASN expression in premalignant lesions and cervical cancer samples and the effects of a FASN inhibitor on cervical cancer cells. FASN expression was observed in all cervical cancer samples with increased expression at more advanced cervical cancer stages. The FASN inhibitor (orlistat) reduced the in vitro cell viability of cervical cancer cells (C-33A, ME-180, HeLa and SiHa) in a time-dependent manner and triggered apoptosis. FASN inhibitor also led to cell cycle arrest and autophagy. FASN may be a potential therapeutic target for cervical cancer, and medicinal chemists, pharmaceutical researchers and formulators should consider this finding in the development of new treatment approaches for this cancer type.

[1]  A. Brenner,et al.  First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors , 2021, EClinicalMedicine.

[2]  Azhar Ali,et al.  Fatty Acid Synthase: An Emerging Target in Cancer , 2020, Molecules.

[3]  V. Pandey,et al.  Drug resistance in cancer: mechanisms and tackling strategies , 2020, Pharmacological Reports.

[4]  A. Mika,et al.  In Vivo Effectiveness of Orlistat in the Suppression of Human Colorectal Cancer Cell Proliferation , 2019, AntiCancer Research.

[5]  Hong-Zin Lee,et al.  Orlistat Displays Antitumor Activity and Enhances the Efficacy of Paclitaxel in Human Hepatoma Hep3B Cells. , 2019, Chemical research in toxicology.

[6]  E. Mao,et al.  Regulation of fatty acid synthesis in immune cells , 2018, Scandinavian journal of immunology.

[7]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[8]  Leilei Xia,et al.  Integrated Analysis of a Competing Endogenous RNA Network Revealing a Prognostic Signature for Cervical Cancer , 2018, Front. Oncol..

[9]  C. Sadasivan,et al.  In silico screening for identification of fatty acid synthase inhibitors and evaluation of their antiproliferative activity using human cancer cell lines , 2018, Journal of receptor and signal transduction research.

[10]  Qiao Wang,et al.  Orlistat induces apoptosis and protective autophagy in ovarian cancer cells: involvement of Akt-mTOR-mediated signaling pathway , 2018, Archives of Gynecology and Obstetrics.

[11]  A. Dueñas-González,et al.  Orlistat as a FASN inhibitor and multitargeted agent for cancer therapy , 2018, Expert opinion on investigational drugs.

[12]  Emma L. Koppe,et al.  An unexpected link between fatty acid synthase and cholesterol synthesis in proinflammatory macrophage activation , 2018, The Journal of Biological Chemistry.

[13]  J. Clohessy,et al.  Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non‐small cell lung cancer , 2018, EMBO Molecular Medicine.

[14]  M. V. Vander Heiden,et al.  The redox requirements of proliferating mammalian cells , 2018, The Journal of Biological Chemistry.

[15]  Xiaodong Li,et al.  Orlistat treatment induces apoptosis and arrests cell cycle in HSC-3 oral cancer cells. , 2017, Microbial pathogenesis.

[16]  E. Sokołowska,et al.  Orlistat Reduces Proliferation and Enhances Apoptosis in Human Pancreatic Cancer Cells (PANC-1). , 2017, Anticancer research.

[17]  G. Duke,et al.  Fatty acid synthase - Modern tumor cell biology insights into a classical oncology target. , 2017, Pharmacology & therapeutics.

[18]  N. Azad,et al.  Anti‐Tumorigenic Potential of a Novel Orlistat‐AICAR Combination in Prostate Cancer Cells , 2017, Journal of cellular biochemistry.

[19]  Chunxiao Zhou,et al.  Effects of Fatty Acid Synthase Inhibition by Orlistat on Proliferation of Endometrial Cancer Cell Lines , 2016, Targeted Oncology.

[20]  G. Duke,et al.  Direct Inhibition of Cellular Fatty Acid Synthase Impairs Replication of Respiratory Syncytial Virus and Other Respiratory Viruses , 2015, PloS one.

[21]  L. Yet,et al.  Progress in the development of fatty acid synthase inhibitors as anticancer targets. , 2015, Bioorganic & medicinal chemistry letters.

[22]  M. Rizvi,et al.  EMT in cervical cancer: its role in tumour progression and response to therapy. , 2015, Cancer letters.

[23]  R. Kalff,et al.  Overexpression of fatty acid synthase in human gliomas correlates with the WHO tumor grade and inhibition with Orlistat reduces cell viability and triggers apoptosis , 2014, Journal of Neuro-Oncology.

[24]  Hua Li,et al.  Fatty Acid Synthase Mediates the Epithelial-Mesenchymal Transition of Breast Cancer Cells , 2014, International journal of biological sciences.

[25]  Jian-Ting Zhang,et al.  Molecular mechanisms of fatty acid synthase (FASN)-mediated resistance to anti-cancer treatments. , 2014, Advances in biological regulation.

[26]  T. Salo,et al.  The Fatty Acid Synthase Inhibitor Orlistat Reduces the Growth and Metastasis of Orthotopic Tongue Oral Squamous Cell Carcinomas , 2013, Molecular Cancer Therapeutics.

[27]  S. Guterres,et al.  Poly(ϵ-caprolactone) microcapsules and nanocapsules in drug delivery , 2013, Expert opinion on drug delivery.

[28]  R. Coletta,et al.  The fatty acid synthase inhibitor orlistat reduces experimental metastases and angiogenesis in B16-F10 melanomas , 2012, British Journal of Cancer.

[29]  Chi-Tang Ho,et al.  Osthole suppresses hepatocyte growth factor (HGF)-induced epithelial-mesenchymal transition via repression of the c-Met/Akt/mTOR pathway in human breast cancer cells. , 2011, Journal of agricultural and food chemistry.

[30]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[31]  P. Kocbek,et al.  Nanosized particles of orlistat with enhanced in vitro dissolution rate and lipase inhibition. , 2010, International journal of pharmaceutics.

[32]  J. Menéndez,et al.  Infection with HIV and HCV enhances the release of fatty acid synthase into circulation: evidence for a novel indicator of viral infection , 2010, BMC gastroenterology.

[33]  W. Hahn,et al.  Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer. , 2009, Journal of the National Cancer Institute.

[34]  M. Loda,et al.  Cohort study of fatty acid synthase expression and patient survival in colon cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  M. Loda,et al.  Fatty acid synthase inhibition with Orlistat promotes apoptosis and reduces cell growth and lymph node metastasis in a mouse melanoma model , 2008, International journal of cancer.

[36]  Simon C Watkins,et al.  Fatty acid synthase is up‐regulated during hepatitis C virus infection and regulates hepatitis C virus entry and production , 2008, Hepatology.

[37]  S. Kridel,et al.  Fatty acid synthase activity in tumor cells. , 2008, Sub-cellular biochemistry.

[38]  J. Menéndez,et al.  Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis , 2007, Nature Reviews Cancer.

[39]  S. Franceschi,et al.  Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis update , 2007, International journal of cancer.

[40]  J. Menéndez,et al.  Pharmacological inhibitors of Fatty Acid Synthase (FASN)--catalyzed endogenous fatty acid biogenesis: a new family of anti-cancer agents? , 2006, Current pharmaceutical biotechnology.

[41]  F. Kuhajda,et al.  Fatty acid synthase and cancer: new application of an old pathway. , 2006, Cancer research.

[42]  R. Franklin,et al.  ‘Why do tumour cells glycolyse?’: From glycolysis through citrate to lipogenesis , 2005, Molecular and Cellular Biochemistry.

[43]  Jeffrey W. Smith,et al.  A Fatty Acid Synthase Blockade Induces Tumor Cell-cycle Arrest by Down-regulating Skp2* , 2004, Journal of Biological Chemistry.

[44]  Jeffrey W. Smith,et al.  Orlistat Is a Novel Inhibitor of Fatty Acid Synthase with Antitumor Activity , 2004, Cancer Research.

[45]  Massimo Loda,et al.  Fatty acid synthase: A metabolic oncogene in prostate cancer? , 2004, Journal of cellular biochemistry.

[46]  C. Townsend,et al.  Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells. , 2003, Cancer research.

[47]  J. Swinnen,et al.  Fatty acid synthase drives the synthesis of phospholipids partitioning into detergent-resistant membrane microdomains. , 2003, Biochemical and biophysical research communications.

[48]  A. Nashimoto,et al.  Fatty acid synthase is highly expressed in carcinoma, adenoma and in regenerative epithelium and intestinal metaplasia of the stomach , 2002, Histopathology.

[49]  Toshimitsu Suzuki,et al.  Overexpression of Fatty Acid Synthase in Oesophageal Squamous Cell Dysplasia and Carcinoma , 2002, Pathobiology.

[50]  H. Isbell.  METABOLISM OF NEOPLASTIC TISSUE , 2001 .

[51]  D. Heimburger,et al.  The expression of fatty acid synthase (FASE) is an early event in the development and progression of squamous cell carcinoma of the lung. , 2000, Human pathology.

[52]  J. Peto,et al.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide , 1999, The Journal of pathology.

[53]  P. Visca,et al.  Fatty Acid Synthase (Fas) Predictive Strength in Poorly Differentiated Early Breast Carcinomas , 1999, Tumori.

[54]  S. Chirala,et al.  Human fatty acid synthase: properties and molecular cloning. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[55]  A. Östör,et al.  Natural history of cervical intraepithelial neoplasia: a critical review. , 1993, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[56]  H. Kolb,et al.  Fatty-acid biosynthesis in man, a pathway of minor importance. Purification, optimal assay conditions, and organ distribution of fatty-acid synthase. , 1986, Biological chemistry Hoppe-Seyler.